Case Control Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Dec 14, 2020; 26(46): 7338-7351
Published online Dec 14, 2020. doi: 10.3748/wjg.v26.i46.7338
Figure 1
Figure 1 Distinct serum microbiome feature associated with intrahepatic cholestasis in pregnancy patients. A: Bray-Curtis principal analysis of metabolites shows significant differences between intrahepatic cholestasis in pregnancy and healthy controls; B: Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis of metabolites identified in this study. The metabolites identified were subjected to a pathway enrichment analysis using the Kyoto Encyclopedia of Genes and Genomes database. Only significantly enriched Kyoto Encyclopedia of Genes and Genomes functional categories (P < 0.05) are depicted according to their P-values. CTL: Control; ICP: Intrahepatic cholestasis in pregnancy; KEGG: Kyoto Encyclopedia of Genes and Genomes.